US 8030333
Benzimidazole compound crystal
granted A61KA61K31/4439A61P
Quick answer
US patent 8030333 (Benzimidazole compound crystal) held by Takeda Pharmaceutical Company Limited expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/4439, A61P, A61P1/00, A61P1/04